20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2160L1 | YAP-TEAD-IN-1 acetate | YAP-TEAD-IN-1 acetate (1659305-78-8 Free base) | YAP |
YAP-TEAD-IN-1 acetate is an effective and competitive inhibitor of YAP–TEAD interaction with an IC50 of 25 nM. | |||
TP2160L | YAP-TEAD-IN-1 TFA | Others | |
YAP-TEAD-IN-1 TFA is a competitive inhibitor of YAP–TEAD interaction (IC50: 25 nM). It shows a higher binding affinity to TEAD1 (Kd: 15 nM) than YAP (50-171) (Kd: 40 nM). | |||
TP2160 | YAP-TEAD-IN-1 | Others | |
YAP-TEAD-IN-1 is a competitive inhibitor of YAP–TEAD interaction (IC50: 25 nM). It shows a higher binding affinity to TEAD1 (Kd: 15 nM) than YAP (50-171) (Kd: 40 nM). | |||
T83951 | TM2 TEAD inhibitor | ||
TM2 TEAD inhibitor, a robust and reversible inhibitor of the TEA domain transcription factor, presents dual inhibitory concentrations (IC50) of 38 nM for TEAD4 auto-palmitoylation and 156 nM for TEAD2 palmitoylation. It ... | |||
T77725 | YAP-TEAD-IN-3 | IAG933 | YAP |
YAP-TEAD-IN-3 is an inhibitor of YAP/TAZ-TEAD interactions with an IC50 of 9 nM for Avi-human TEAD (4217-434). YAP-TEAD-IN-3 inhibits YAP reporter gene expression (IC50 = 0.048 μM) and NCI-H2052 cell proliferation (IC50 ... | |||
T72888 | YAP-TEAD-IN-2 | YAP | |
YAP-TEAD-IN-2 (compound 6) serves as a potent inhibitor of the YAP-TEAD protein-protein interaction (PPI), demonstrating an inhibitory concentration 50 (IC50) value of 2.7 nM [1]. | |||
T61776 | TEAD-IN-2 | ||
TEAD-IN-2 is an innovative, orally bioavailable inhibitor that targets the transcriptional enhancer associate domain (TEAD). It functions by regulating TEAD through ubiquitination and/or degradation by specific compounds... | |||
T79687 | TEAD-IN-6 | YAP | |
TEAD-IN-6 (Example 11-1) is a TEAD modulator that inhibits the YAP1/TAZ-TEAD interaction, and has applications in cancer research [1]. | |||
T62597 | TEAD-IN-3 | ||
TEAD-IN-3 (compound I-177) is a potent inhibitor of the TEAD transcription factor, which can be used to study proliferative diseases such as cancer. | |||
T8421 | TED-347 | YAP | |
TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability. | |||
T9954 | K-975 | Others | |
K-975 is a highly selective, orally active TEAD inhibitor, effectively inhibiting protein-protein interactions between TEAD and YAP1/TAZ. | |||
T9032 | MGH-CP1 | Others | |
MGH-CP1 is a potent and selective inhibitor TEAD palmitoylation. It exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively. | |||
T22372 | MYF-01-37 | 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one | Others , YAP |
MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) is a novel covalent TEAD inhibitor. | |||
T64342 | DC-TEADin02 | YAP | |
DC-TEADin02 is an inhibitor of TEAD auto palmitoylation (IC50 = 197 nM). DC-TEADin02 can be in studies about development, regeneration, and tissue homeostasis. | |||
T77580 | IK-930 | compound I-32 | YAP |
IK-930 is an orally active TEAD inhibitor (EC50 < 0.1 µM) with potent potency. | |||
T3112 | Verteporfin | BPD-MA,CL 318952 | Apoptosis , YAP , VDA , Autophagy |
Verteporfin (BPD-MA) is a YAP inhibitor that inhibits YAP-TEAD interactions. Verteporfin is also a photosensitizer used in photodynamic therapy. Verteporfin also induces apoptosis and inhibits autophagy. | |||
T60148 | MSC-4106 | YAP | |
MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model [1]. | |||
T35545 | VT107 | YAP | |
VT107 is a potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancer[1]. | |||
T62077 | VT103 | VT-103,VT 103 | YAP |
VT103 is an orally active and selective inhibitor of TEAD1 protein palmitoylation and is an analog of VT101. VT103 has potential antitumor activity by inhibiting YAP/TAZ-TEAD-promoted gene transcriptionment, blocking TEA... | |||
T69638 | VT-105 | VT 105 | Others |
VT-105 is a potent and selective TEAD autopalmitoylation inhibitor that inhibits proliferation and tumour growth in NF2-deficient mesotheliomas. |